Myocardial redox status, catecholamine metabolism and post-operative arrhythmia

心肌氧化还原状态、儿茶酚胺代谢与术后心律失常

基本信息

  • 批准号:
    9102173
  • 负责人:
  • 金额:
    $ 4.27万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-07-01 至 2016-10-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The onset of post-operative atrial fibrillation (POAF) after cardiac surgery continues to be the most common and costly post-operative complication. Despite rigorous investigation of POAF by physicians and scientists, significant gaps remain in our understanding as to why it occurs, and specifically why it only occurs in certain patients. Our laboratory has obtained exciting preliminary data showing that high activity of the enzyme monoamine oxidase (MAO), a mitochondrial outer membrane-bound enzyme and substantial generator of H2O2 in atrial myocardium, is strongly correlated with POAF independent of other known risk factors. So are, to a lesser extent, glutathione (GSH) and glutathione peroxidase (GPx), both critical for maintaining intracellular redox balance. These enzymes were all measured in discarded right atrial appendage (RAA) obtained during cardiac surgery. From a mechanistic perspective, these findings are compelling and scientifically plausible because they integrate catecholamine overload, mitochondrial dysfunction and redox imbalance in the atrial myocardium, all factors in the peri-operative period that are known to contribute to arrhythmogenesis. In the current proposal, by obtaining tissue and performing analyses using a much larger cohort of cardiac surgery patients, we will build on this highly promising data in order to establish a statistical model of POAF risk based on MAO as a predictive biomarker, and to elucidate mechanisms connecting elevated MAO activity in right atrium to POAF by focusing specifically on mitochondrial energetics in the atrial cardiomyocytes. In Aim 1, we will validate MAO as a predictive biomarker of POAF, alone or in combination with other redox enzymes, by obtaining the RAA tissue intra-operatively from a large cohort (N=770) of adult patients undergoing cardiac surgery and immediately measuring activity of these enzymes. As an exploratory component of this Aim we will examine if MAO and/or GPx in platelets and RBC's, respectively, obtained pre- operatively from this same cohort of patients, can alternatively be used as predictive biomarkers of POAF. In Aim 2, using a much smaller subset of the patient cohort recruited for Aim 1, we will begin to dissect mechanisms by which high MAO activity in atrium leads to POAF by focusing on the interaction between MAO and mitochondrial function in atrial myocardium. Thus, these studies will have both a practical, applied research component (Aim 1) as well as a basic research component (Aim 2). It is anticipated that the findings from the first Aim will have immediate and sustained clinical impact because they will provide clinicians the ability to predict with high probability which patients are predisposed and therefor at high risk to develop POAF. This would create a pathway to specifically target the 'high-risk' patients with prophylactic anti- arrhythmic medication in the near future. We expect the findings from our basic research on interactions between cardiac MAO and mitochondrial energetics to enhance our understanding of mechanisms connecting high levels of MAO activity in right atrium to POAF.
描述(由申请人提供):心脏手术后发生房颤(POAF)仍然是最常见和最昂贵的术后并发症。尽管医生和科学家对POAF进行了严格的调查,但我们对其发生原因的理解仍然存在重大差距,特别是为什么它只发生在某些患者身上。我们的

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ethan John Anderson其他文献

Ethan John Anderson的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Ethan John Anderson', 18)}}的其他基金

Determinants of cardioprotection by circulating prohibitin-1 during sepsis
败血症期间循环抑制素 1 的心脏保护作用的决定因素
  • 批准号:
    10577340
  • 财政年份:
    2023
  • 资助金额:
    $ 4.27万
  • 项目类别:
Myocardial redox status, catecholamine metabolism and post-operative arrhythmia
心肌氧化还原状态、儿茶酚胺代谢与术后心律失常
  • 批准号:
    9295043
  • 财政年份:
    2016
  • 资助金额:
    $ 4.27万
  • 项目类别:
Myocardial redox status, catecholamine metabolism and post-operative arrhythmia
心肌氧化还原状态、儿茶酚胺代谢与术后心律失常
  • 批准号:
    8674060
  • 财政年份:
    2014
  • 资助金额:
    $ 4.27万
  • 项目类别:
Linking redox chemistry and mitochondria in atrium to post-operative arrhythmia
将心房中的氧化还原化学和线粒体与术后心律失常联系起来
  • 批准号:
    8092793
  • 财政年份:
    2010
  • 资助金额:
    $ 4.27万
  • 项目类别:
Linking redox chemistry and mitochondria in atrium to post-operative arrhythmia
将心房中的氧化还原化学和线粒体与术后心律失常联系起来
  • 批准号:
    7990522
  • 财政年份:
    2010
  • 资助金额:
    $ 4.27万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了